Anixa Biosciences Inc (NASDAQ:ANIX)
| 3.29 Delayed Data As of May 24 |  -0.005 / -0.15%Today’s Change | 2.30 Today|||52-Week Range 5.87 | +10.77% Year-to-Date |
Latest ANIX News | Press Releases
No recent news for Anixa Biosciences Inc.
Today’s Trading
| Previous close | 3.29 |
| Today’s open | 3.26 |
| Day’s range | 2.87 - 3.33 |
| Volume | 148,387 |
| Average volume (3 months) | 73,103 |
| Market cap | $98.9M |
Data as of 4:00pm ET, 05/24/2022
Growth & Valuation
| Earnings growth (last year) | -0.58% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 265.99 |
| Price/Book | 2.78 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CSBRChampions Oncology I... | 0.00 | 0.00% |
| LPTXLeap Therapeutics In... | -0.02 | -1.75% |
| LJPCLa Jolla Pharmaceuti... | -0.07 | -1.83% |
| EQEquillium Inc | -0.24 | -8.48% |
Data as of 4:00pm ET, 05/24/2022
Financials
| Next reporting date | June 14, 2022 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $512.5K |
| Annual profit (last year) | -$13.0M |
| Net profit margin | -2,527.69% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Jose, California |
Forecasts
